The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
On January 17, 2025, the staff at the Federal Trade Commission (FTC) released their first results from the FTC’s Surveillance Pricing market ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...
A staff report released Friday by the FTC suggested partnerships between OpenAI and Microsoft, and Amazon and Anthropic, ...
The U.S. Federal Trade Commission (FTC) on Friday found that the partnerships between Microsoft ( NASDAQ: MSFT ), Amazon ( ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
In the report, the FTC said pharmacy benefit managers (PBMs), charge significant markups for cancer, HIV, and other critical ...
Surmodics (NASDAQ:SRDX) dropped 5.8% after a report about the Federal Trade Commission's review of its planned sale to private equity firm GTCR. The staff of the FTC has some concerns about the $627 ...
The Federal Trade Commission (FTC) said in a staff report issued Friday that there are potential competitive issues in ...
The Federal Trade Commission has issued a warning about phony text messages sent to residents about supposed tolls they owe. The surge in SMS spam has been linked to increased activity by foreign bad ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.